Saxagliptin for the treatment of type 2 diabetes mellitus: Focus on recent studies

ISSN： 0785-3890

Source： Annals of Medicine, Vol.44, Iss.2, 2012-03, pp. : 157-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Saxagliptin: a New DPP-4 inhibitor for the treatment of type 2 diabetes mellitus

By Tahrani Abd Piya Milan Barnett Anthony

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 736-736

Springer Publishing Company

Access to resources Recommend Favorite

Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes

By Rosenstock J. Aguilar-Salinas C. Klein E. Nepal S. List J. Chen R.

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2401-2411

Informa Healthcare

Access to resources Recommend Favorite

Treatment intensification in type 2 diabetes mellitus and obesity

By Zawiejska Agnieszka McAleese Jane Yemparala Prasad Taheri Shahrad

British Journal of General Practice, Vol. 63, Iss. 609, 2013-04 ,pp. : 182-182

Royal College of General Practitioners

Access to resources Recommend Favorite

Perceptions and experiences of taking oral medications for the treatment of Type 2 diabetes mellitus: a systematic review and meta‐synthesis of qualitative studies

DIABETIC MEDICINE, Vol. 33, Iss. 10, 2016-10 ,pp. : 1330-1338

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fixed-dose combination rosiglitazone/glimepiride in the treatment of Type 2 diabetes mellitus

By Derosa Giuseppe Salvadeo Sibilla AT Cicero Arrigo FG

Therapy, Vol. 3, Iss. 5, 2006-09 ,pp. : 559-569

Future Medicine

Access to resources Recommend Favorite